Showing results (171-180 of 440) with videos related to
Sort By:
Pageof 44
The Journal of Biological Chemistry|April 27, 2000
Type II cAMP-dependent protein kinase-deficient Drosophila are viable but show developmental, circadian, and drug response phenotypesS K Park, S A Sedore, C Cronmiller, et al.Circulation|November 1, 1993
Heparin binding proteins. Contribution to heparin rebound after cardiopulmonary bypassK H Teoh, E Young, C A Bradley, et al.Genes & Development|August 1, 1989
Embryonic expression pattern of a family of Drosophila proteins that interact with a central nervous system regulatory elementS J Bray, B Burke, N H Brown, et al.Annals of Internal Medicine|July 15, 1993
Establishing a therapeutic range for heparin therapyP Brill-Edwards, J S Ginsberg, M Johnston, et al.Archives of Internal Medicine|July 1, 1989
Intermittent compression units for the postphlebitic syndrome. A pilot studyJ S Ginsberg, P Brill-Edwards, G Kowalchuk, et al.Journal of Thrombosis and Haemostasis : JTH|August 12, 2004
Use of different D-dimer levels to exclude venous thromboembolism depending on clinical pretest probabilityL A Linkins, S M Bates, J S Ginsberg, et al.Neurology|May 1, 1977
Prevention of venous thrombosis in patients with intracranial disease by intermittent pneumatic compression of the calfA G Turpie, A Gallus, W S Beattie, et al.Thrombosis and Haemostasis|April 25, 1989
Risks to the fetus of radiologic procedures used in the diagnosis of maternal venous thromboembolic diseaseJ S Ginsberg, J Hirsh, A J Rainbow, et al.The Journal of Laboratory and Clinical Medicine|August 1, 1996
Reliability of the international normalized ratio for monitoring the induction phase of warfarin: comparison with the prothrombin time ratioM Johnston, L Harrison, K Moffat, et al.Archives of Internal Medicine|October 20, 1998
Assessment of outpatient treatment of deep-vein thrombosis with low-molecular-weight heparinL Harrison, J McGinnis, M Crowther, et al.Pageof 44